Clinical study on the treatment of upper limb dysfunction in stroke patients using eye acupuncture combined with mirror therapy

注册号:

Registration number:

ITMCTR2024000865

最近更新日期:

Date of Last Refreshed on:

2024-12-25

注册时间:

Date of Registration:

2024-12-25

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

眼针联合镜像疗法对脑卒中患者上肢功能障碍治疗的临床研究

Public title:

Clinical study on the treatment of upper limb dysfunction in stroke patients using eye acupuncture combined with mirror therapy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

眼针联合镜像疗法对脑卒中患者上肢功能障碍治疗的临床研究

Scientific title:

Clinical study on the treatment of upper limb dysfunction in stroke patients using eye acupuncture combined with mirror therapy

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘继业

研究负责人:

刘继业

Applicant:

Liu jiye

Study leader:

Liu jiye

申请注册联系人电话:

Applicant telephone:

17704286805

研究负责人电话:

Study leader's telephone:

17704286805

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

17704286805@163.com

研究负责人电子邮件:

Study leader's E-mail:

17704286805@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

葫芦岛市连山大街15号

研究负责人通讯地址:

葫芦岛市连山大街15号

Applicant address:

No. 15 Lianshan Street Huludao City

Study leader's address:

No. 15 Lianshan Street Huludao City

申请注册联系人邮政编码:

Applicant postcode:

125001

研究负责人邮政编码:

Study leader's postcode:

125001

申请人所在单位:

葫芦岛市中心医院

Applicant's institution:

Huludao Central Hospital

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

KY202422

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

葫芦岛市中心医院伦理委员会

Name of the ethic committee:

Ethics Review Committee of Huludao Central Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024/10/31 0:00:00

伦理委员会联系人:

张曼

Contact Name of the ethic committee:

Zhang man

伦理委员会联系地址:

葫芦岛市连山大街15号

Contact Address of the ethic committee:

No. 15 Lianshan Street Huludao City

伦理委员会联系人电话:

Contact phone of the ethic committee:

17704293335

伦理委员会联系人邮箱:

Contact email of the ethic committee:

17704293335@163.com

研究实施负责(组长)单位:

葫芦岛市中心医院

Primary sponsor:

Huludao Central Hospital

研究实施负责(组长)单位地址:

葫芦岛市连山大街15号

Primary sponsor's address:

No. 15 Lianshan Street Huludao City

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

辽宁省

市(区县):

--请选择--

Country:

China

Province:

Liaoning

City:

----

单位(医院):

葫芦岛市中心医院

具体地址:

15 lianshan street

Institution
hospital:

Huludao Central Hospital

Address:

15 lianshan street

经费或物资来源:

自筹

Source(s) of funding:

raise independently

研究疾病:

中风

研究疾病代码:

Target disease:

Stroke

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

通过眼针联合镜像疗法减轻脑卒中患者的上肢功能障碍

Objectives of Study:

Reducing upper limb dysfunction in stroke patients through eye acupuncture combined with mirror therapy

药物成份或治疗方案详述:

三组病人全部采用脑血管病科相应基础疗法。A组由专业康复师指导患者进行上肢康复训练。所有训练每天1次,每次共持续时间为5h,每周休息2天,6周为1个疗程。 B组在A组常规训练的基础上,再应用镜像疗法。 C组在B组的基础上给予眼针治疗

Description for medicine or protocol of treatment in detail:

All three groups of patients received corresponding basic therapies from the Department of Cerebrovascular Diseases. Group A is guided by professional rehabilitation therapists to conduct upper limb rehabilitation training for patients. All training sessions are conducted once a day, with a total duration of 5 hours each session. There are 2 days of rest per week, and 6 weeks constitute one course of treatment. On the basis of routine training in Group A, Group B applied mirror therapy. Group C received eye acupuncture treatment on the basis of Group B

纳入标准:

①均经过头CT或者MRI证实,符合脑梗死或脑出血的影像学表现②首次发病,且病程均小于3个月③年龄35—75之间④患侧上肢Brunnstrom分期为III期或III期以上⑤患侧上肢肌张力不高于II级(改良Ashworth评定,Modified Ashworth Scale,MAS)⑥生命体征平稳,无严重认知、理解功能障碍。洛文斯顿作业疗法认知评定成套试验记录表(loewenstein occupational therapy cognitive assessment,LOTCA)评分不小于40分⑦无严重心、肝、肾等脏器疾病⑧家属知情同意且经过医院伦理委员会批准。

Inclusion criteria

① Confirmed by head CT or MRI the imaging findings are consistent with cerebral infarction or cerebral hemorrhage. ② First onset with a course of less than 3 months. ③ Age between 35-75. ④ Brunstrom stage of the affected upper limb is stage III or above. ⑤ Muscle tone of the affected upper limb is not higher than stage II (Modified Ashworth Scale MAS). ⑥ Vital signs are stable without severe cognitive or comprehension dysfunction. The Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) score should not be less than 40 points. ⑦ There should be no serious heart liver kidney or other organ diseases. ⑧ Family members should give informed consent and be approved by the hospital ethics committee.

排除标准:

①因各种原因引起的疼痛从而影响上肢各关节活动。例如肩手综合征、肘关节挛缩等②伴有其他严重疾病,无法完成本次试验。例如循环、呼吸系统相关疾患以及具有凝血功能障碍或者严重出血倾向的病患③严重认知障碍以及曾患有精神类疾病的患者④入组前1个月,接受过其他药物临床试验的病人

Exclusion criteria:

① Pain caused by various reasons can affect the movement of various joints in the upper limbs. For example shoulder hand syndrome elbow joint contracture etc. ② accompanied by other serious diseases cannot complete this experiment. For example patients with circulatory and respiratory system related diseases as well as those with coagulation dysfunction or severe bleeding tendency. Patients with severe cognitive impairment and those who have previously suffered from psychiatric disorders. Patients who have undergone clinical trials of other drugs in the previous month before enrollment

研究实施时间:

Study execute time:

From 2024-10-31

To      2025-10-31

征募观察对象时间:

Recruiting time:

From 2024-12-27

To      2025-06-10

干预措施:

Interventions:

组别:

常规组

样本量:

30

Group:

Regular Group

Sample size:

干预措施:

上肢康复训练

干预措施代码:

Intervention:

Upper limb rehabilitation training

Intervention code:

组别:

眼针组

样本量:

30

Group:

Eye needle group

Sample size:

干预措施:

眼针联合镜像并结合上肢训练

干预措施代码:

Intervention:

Eye acupuncture combined with mirror imaging and upper limb training

Intervention code:

组别:

镜像组

样本量:

30

Group:

Mirror Group

Sample size:

干预措施:

镜像疗法联合上肢康复训练

干预措施代码:

Intervention:

Mirror therapy combined with upper limb rehabilitation training

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

辽宁

市(区县):

--请选择--

Country:

China

Province:

Liaoning

City:

----

单位(医院):

葫芦岛市中心医院

单位级别:

三级甲等

Institution/hospital:

Huludao Central Hospital

Level of the institution:

Grade III Grade A

测量指标:

Outcomes:

指标中文名:

改良Barthel指数评定量表

指标类型:

次要指标

Outcome:

modified Barthel index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

改良Ashworth评定

指标类型:

次要指标

Outcome:

Improved Ashworth assessment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Fugl-Meyer上肢运动功能量表

指标类型:

主要指标

Outcome:

Fugl Meyer Upper Limb Motor Function Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 35
Min age years
最大 75
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

独立的专业医生通过随机数字表法产生随机序列

Randomization Procedure (please state who generates the random number sequence and by what method):

Independent professional doctors generate random sequences using the random number table method

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2025-11-1 通过17704286805@163.com获取

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

The data was obtained through the above-mentioned email

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1.病例记录表2.ResMan

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1.Case Record Form2.Electronic Data Capture

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above